 LA JOLLA, Calif., June 07, 2021 GLOBE NEWSWIRE -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market NASDAQ:MNOV and the JASDAQ Market of the Tokyo Stock Exchange Code Number: 4875, today announced it has initiated a sheep study to investigate MN-166 ibudilast in an ovine model of chlorine-induced acute lung injury. Following treatment of the sheep with MN-166 ibudilast or control, the study will evaluate pulmonary function, lung injury and edema formation, cardiopulmonary hemodynamics, and systemic vascular permeability. 